Inhibition of Mouse B16 Melanoma by Sodium Butyrate Correlated to Tumor Associated Macrophages Differentiation Suppression

Overview

Journal Int J Clin Exp Med

Specialty General Medicine

Date 2015 Jun 12

PMID 26064327

Citations 7

Authors

Fen Xiong

Yun-Zhu Mou

Xiao-Yan Xiang

Affiliations

Soon will be listed here.

Abstract

Objective: As one member of the histone deacetylase inhibitor (HDACi) family, Sodium butyrate (NaB) was found out that could be used as a differentiation inducer of much cancer cell. But its effects on tumor microenvironment cells are not well recognized. The goal of this research is to investigate the effect of NaB on B16 melanoma and analysis its relevant mechanism.

Methods: We observed the effect of sodium butyrate on B16 melanoma in vivo and in vitro. MTT method was performed to detect cell apoptosis rate after treatment. Tumor associated macrophage infiltration condition was detected by flow cytometry. Western-blotting and immunohistochemical method were used to detect the expression of tumor associated macrophage cytokines.

Results: A certain concentration of sodium butyrate could effectively inhibit B16 melanoma growth in vivo and in vitro, and this inhibition effects related to the suppression of tumor associated macrophage differentiation. At the same time we observed the relevant macrophage factors were down-regulated compared to the control.

Conclusion: Sodium butyrate could effectively inhibit B16 melanoma growth through suppressing tumor associated macrophage proliferation and reduce relevant pro-tumor macrophage factors expression, which may help to promote the clinical study of melanoma epigenetic therapy.

Citing Articles

Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives.

Chianese A, Santella B, Ambrosino A, Stelitano D, Rinaldi L, Galdiero M Cancers (Basel). 2021; 13(11).

PMID: 34199429 PMC: 8199618. DOI: 10.3390/cancers13112761.

Butyric Acid from Probiotic in the Skin Microbiome Down-Regulates the Ultraviolet-Induced Pro-Inflammatory IL-6 Cytokine via Short-Chain Fatty Acid Receptor.

Keshari S, Balasubramaniam A, Myagmardoloonjin B, Herr D, Negari I, Huang C Int J Mol Sci. 2019; 20(18).

PMID: 31514281 PMC: 6769796. DOI: 10.3390/ijms20184477.

Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids.

Lajko E, Spring S, Hegedus R, Biri-Kovacs B, Ingebrandt S, Mezo G Beilstein J Org Chem. 2018; 14:2495-2509.

PMID: 30344773 PMC: 6178282. DOI: 10.3762/bjoc.14.226.

Icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway.

Wang D, Xu W, Chen X, Han J, Yu L, Gao C Oncotarget. 2017; 8(59):99504-99513.

PMID: 29245919 PMC: 5725110. DOI: 10.18632/oncotarget.20118.

Histone deacetylase inhibitor NaBut suppresses cell proliferation and induces apoptosis by targeting p21 in multiple myeloma.

Yao R, Han D, Sun X, Fu C, Wu Q, Yao Y Am J Transl Res. 2017; 9(11):4994-5002.

PMID: 29218097 PMC: 5714783.

References

Drummond D, Noble C, Kirpotin D, Guo Z, Scott G, Benz C . Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol. 2005; 45:495-528. DOI: 10.1146/annurev.pharmtox.45.120403.095825. View

Florenes V, Skrede M, Jorgensen K, Nesland J . Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. Melanoma Res. 2004; 14(3):173-81. DOI: 10.1097/01.cmr.0000129576.49313.26. View

Marthyn P, Beuscart A, Coll J, Moreau-Gachelin F, Righi M . DMSO reduces CSF-1 receptor levels and causes apoptosis in v-myc immortalized mouse macrophages. Exp Cell Res. 1998; 243(1):94-100. DOI: 10.1006/excr.1998.4149. View

Sandor V, Bakke S, Robey R, Kang M, Blagosklonny M, Bender J . Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res. 2002; 8(3):718-28. View

Takasaki S, Leive L . Induction by dimethyl sulfoxide of Fc fragment-mediated phagocytosis in the mouse macrophage-like cell line P388D1. Proc Natl Acad Sci U S A. 1982; 79(16):4980-4. PMC: 346809. DOI: 10.1073/pnas.79.16.4980. View

Bandyopadhyay D, Mishra A, Medrano E . Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway. Cancer Res. 2004; 64(21):7706-10. DOI: 10.1158/0008-5472.CAN-03-3897. View

Mantovani A, Sozzani S, Locati M, Allavena P, Sica A . Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23(11):549-55. DOI: 10.1016/s1471-4906(02)02302-5. View

Chen W, Wei F, Xu J, Wang Y, Chen L, Wang J . Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line. Int J Mol Med. 2011; 28(6):985-91. DOI: 10.3892/ijmm.2011.790. View

Jazirehi A . Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy. Anticancer Drugs. 2010; 21(9):805-13. DOI: 10.1097/CAD.0b013e32833dad91. View

10.

Kim Y, Park J, Lee J, Kwon T . Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis. 2004; 25(10):1813-20. DOI: 10.1093/carcin/bgh188. View

11.

Qiu L, Burgess A, Fairlie D, Leonard H, Parsons P, Gabrielli B . Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol Biol Cell. 2000; 11(6):2069-83. PMC: 14904. DOI: 10.1091/mbc.11.6.2069. View

12.

Medina V, Edmonds B, Young G, James R, Appleton S, Zalewski P . Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 1997; 57(17):3697-707. View

13.

Demary K, Wong L, Spanjaard R . Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells. Cancer Lett. 2001; 163(1):103-7. DOI: 10.1016/s0304-3835(00)00676-5. View

14.

Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro M . Macrophage polarization in tumour progression. Semin Cancer Biol. 2008; 18(5):349-55. DOI: 10.1016/j.semcancer.2008.03.004. View

15.

Zhang X, Gillespie S, Borrow J, Hersey P . The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. Mol Cancer Ther. 2004; 3(4):425-35. View